Monsanto says its net income increased 22 percent in the second quarter on strong sales of its biotech seeds.
The agricultural products company boosted its full-year earnings guidance, citing its strong performance in the first two quarters.
The St. Louis company says it earned $1.48 billion, or $2.74 per share in the three months ended Feb. 13. That compares to earnings of $1.21 billion, or $2.24 per share, a year ago.
Genetically-modified seeds — and the technology to produce them — have been at the center of a bitter legal fight between the two companies. Dupont will pay Monsanto more than $1.5 billion in the deal. With that, the companies will drop their patent and antitrust claims against each other.
Last week, the U.S. Supreme Court heard oral arguments in a legal battle between St. Louis-based Monsanto and a 75-year-old farmer from Indiana named Vernon Hugh Bowman.
While some Supreme Court justices have already tipped their hat signifying Monsanto will likely win the case, the issue revolves around whether Bowman violated Monsanto’s patent rights when he planted soybean seeds from a grain elevator.